Volume 7, Issue 3 (7-2019)                   JoMMID 2019, 7(3): 85-86 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Bahrami F, Rafati S. The LeiSHield-MATI consortium: An international project to understand and combat cutaneous leishmaniasis through research and innovation staff exchange. JoMMID 2019; 7 (3) :85-86
URL: http://jommid.pasteur.ac.ir/article-1-193-en.html
The LeiSHield-MATI consortium: An international project to understand and combat cutaneous leishmaniasis through research and innovation staff exchange
Fariborz Bahrami , Sima Rafati *
Department of Immunotherapy and Leishmania Vaccine Research, Pasteur Institute of Iran, Tehran, Iran
Abstract:   (3651 Views)
Not required for a Letter to the Editor.
Keywords: Cutaneous leishmaniasis, Pasteur Institute International Network, Horizon 2020, LeiSHield-MATI RISE
Full-Text [PDF 357 kb]   (1244 Downloads)    
Type of Study: Letter to the Editor | Subject: Microbial pathogenesis
Received: 2019/06/5 | Accepted: 2019/06/23 | Published: 2019/11/3
References
1. Hartley MA, Drexler S, Ronet C, Beverley SM, Fasel N. The immunological, environmental, and phylogenetic perpetrators of metastatic leishmaniasis. Trends Parasitol. 2014; 30(8):412-22. [DOI:10.1016/j.pt.2014.05.006]
2. Bahrami F, Harandi AM, Rafati S. Biomarkers of Cutaneous Leishmaniasis. Front Cell Infect Microbiol. 2018; 8 (article 222). [DOI:10.3389/fcimb.2018.00222]
3. Bahrami F, Spath GF, Rafati S. Old World cutaneous leishmaniasis challenges in Morocco, Algeria, Tunisia and Iran (MATI): a collaborative attempt to combat the disease. Expert Rev Vaccines. 2017; 16(5):415-17. [DOI:10.1080/14760584.2017.1311792]
Add your comments about this article : Your username or Email:
CAPTCHA
Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.